Inventor · disambiguated record
Sung-Sau So
Also filed as: SO SUNG-SAU
55 granted patents·20 pending applications·203 citations·filing 2003–2022
97Inventor score
Files withHOFFMANN LA ROCHE30SAVIRA PHARMACEUTICALS GMBH10MERCK SHARP & DOHME8CHEN LI5FIROOZNIA FARIBORZ4
Top patents by PatentIndex Score
75 records- 0197US7851626B24,4,5,5, tetrasubstituted imidazolinesHOFFMANN LA ROCHE·Filed 2006·Granted Dec 14, 2010·43 cites·33 claims
- 0295US7807674B2Thyroid hormone analogsHOFFMANN LA ROCHE·Filed 2008·Granted Oct 5, 2010·35 cites·19 claims
- 0393US7452882B2Thyroid hormone analogsHOFFMANN LA ROCHE·Filed 2006·Granted Nov 18, 2008·24 cites·11 claims
- 0490US7576082B2Oxindole derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Aug 18, 2009·16 cites·12 claims
- 0588US9180193B2Antiviral compoundsHOFFMANN LA ROCHE·Filed 2012·Granted Nov 10, 2015·8 cites·36 claims
- 0688US9133170B2Inhibitors of HCV NS5AHOFFMANN LA ROCHE·Filed 2012·Granted Sep 15, 2015·8 cites·46 claims
- 0783US9868727B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 16, 2018·3 cites·16 claims
- 0883US8263656B2Substituted aminotetralinesFIROOZNIA FARIBORZ·Filed 2009·Granted Sep 11, 2012·9 cites·26 claims
- 0983US7112676B2Pyrimido compounds having antiproliferative activityHOFFMANN LA ROCHE·Filed 2003·Granted Sep 26, 2006·24 cites·19 claims
- 1079US10123995B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Nov 13, 2018·2 cites·14 claims
- 1179US9783530B2Factor Xla inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 10, 2017·2 cites·14 claims
- 1279USRE46024EThyroid hormone analogsHOFFMANN LA ROCHE·Filed 2015·Granted Jun 7, 2016·2 cites·19 claims
- 1376US10011585B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·2 cites·12 claims
- 1476US8124641B2Aminotetrahydroindazoloacetic acidsCHEN LI·Filed 2009·Granted Feb 28, 2012·2 cites·19 claims
- 1574US10081617B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·2 cites·11 claims
- 1674US8268870B2Aminotetrahydroindazoloacetic acidsCHEN LI·Filed 2011·Granted Sep 18, 2012·2 cites·20 claims
- 1771US7932390B2Substituted thieno[3,2-C]pyridine carboxylic acid derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Apr 26, 2011·1 cites·11 claims
- 1871US7129351B2Pyrimido compounds having antiproliferative activityHOFFMANN LA ROCHE·Filed 2003·Granted Oct 31, 2006·9 cites·18 claims
- 1970US8921388B2Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Dec 30, 2014·2 cites·28 claims
- 2069US11104668B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Aug 31, 2021·0 cites·14 claims
- 2169US9469644B2Inhibitors of Bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Oct 18, 2016·1 cites·17 claims
- 2269US9458105B2Inhibitors of Bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2013·Granted Oct 4, 2016·1 cites·5 claims
- 2368US8729078B2Inhibitors of bruton's tyrosine kinaseBILLEDEAU ROLAND JOSEPH·Filed 2012·Granted May 20, 2014·2 cites·18 claims
- 2468US2020207741A1Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2565US12497403B2Factor XIa inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 16, 2025·0 cites·19 claims
- 2665US9624201B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Apr 18, 2017·0 cites·22 claims
- 2765US9359345B2Thiazole derivatives as inhibitors of Bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2013·Granted Jun 7, 2016·1 cites·20 claims
- 2864US10640491B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2018·Granted May 5, 2020·0 cites·6 claims
- 2964US2020181154A1Pyrazole carboxamide compounds and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
- 3063US9434745B27-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2013·Granted Sep 6, 2016·1 cites·14 claims
- 3162US9199987B2Substituted naphthyridines for the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2014·Granted Dec 1, 2015·0 cites·8 claims
- 3261US10093657B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2017·Granted Oct 9, 2018·0 cites·2 claims
- 3360US8138208B2Aminotetrahydroindazoloacetic acidsCHEN LI·Filed 2009·Granted Mar 20, 2012·0 cites·28 claims
- 3459US8501732B2Aminomethyl quinolone compoundsBILOTTA JOSEPH A·Filed 2012·Granted Aug 6, 2013·1 cites·15 claims
- 3558US9505758B2Substituted 1,5-naphthyridines as endonuclease inhibitorsSAVIRA PHARMACEUTICALS GMBH·Filed 2015·Granted Nov 29, 2016·0 cites·5 claims
- 3658US2019194209A1Pyrazole carboxamide compounds and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 3755US12492187B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·11 claims
- 3855US2017290834A1Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
- 3954US2018057500A1Pyrazole carboxamide compounds and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 4053US8642629B2Naphthylacetic acidsCHEN LI·Filed 2009·Granted Feb 4, 2014·0 cites·47 claims
- 4151US12304899B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted May 20, 2025·0 cites·13 claims
- 4251US8188090B2Naphthylacetic acidsFIROOZNIA FARIBORZ·Filed 2009·Granted May 29, 2012·0 cites·34 claims
- 4351US8124629B2Naphthylacetic acidsFIROOZNIA FARIBORZ·Filed 2009·Granted Feb 28, 2012·0 cites·32 claims
- 4451US2013102601A1Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 4549US9802920B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Oct 31, 2017·0 cites·23 claims
- 4649US8470884B2Alkenyl naphthylacetic acidsHOFFMANN LA ROCHE·Filed 2012·Granted Jun 25, 2013·0 cites·9 claims
- 4749US2013102600A1Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 4848US9556150B2Inhibitors of bruton's tyrosine kinaseHOFFMANN LA ROCHE·Filed 2014·Granted Jan 31, 2017·0 cites·18 claims
- 4948US8420675B2Aminotetrahydroindazoloacetic acidsCHEN LI·Filed 2012·Granted Apr 16, 2013·0 cites·20 claims
- 5047US2016362423A17-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral diseaseSAVIRA PHARMACEUTICALS GMBH·Filed 2016·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sung-Sau So files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →